Search for: "Pharma Card Inc"
Results 1 - 20
of 37
Sorted by Relevance
|
Sort by Date
2 Apr 2021, 3:28 am
April 7, 2021 - 11 AM: In re Electronic Payments Inc. [read post]
27 Jul 2022, 11:00 am
Apple Inc was sued in a proposed class action by payment card issuers accusing the iPhone maker of abusing its market power in mobile devices to thwart competition for its Apple Pay mobile wallet. [read post]
24 Mar 2011, 1:12 pm
Bristol-Myers Squibb, Inc., the employees claim that BMS paid kickbacks to physicians and pharmacists to increase prescriptions and dispensing of the company’s drugs. [read post]
18 Jan 2013, 2:06 pm
The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
5 Nov 2018, 5:51 am
Purdue Pharma L.P., et al. [read post]
1 May 2009, 6:44 am
Pharma Services, Network, Inc. v. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
13 Oct 2016, 6:50 am
However, Trading Technologies has filed a new petition asking whether a new card game is categorically unpatentable so long as it uses a standard deck (rather than a novel deck) of cards. [read post]
20 Jan 2011, 12:50 pm
Hoffmann-La Roche, Inc., 891 A.2d 1229, 1236 (N.J. [read post]
15 Jan 2010, 10:32 pm
Westview Instruments, Inc., 52 F.3d 967, 976 (Fed. [read post]
15 Jan 2008, 3:06 am
UAL Corporation filed 04/30/07 closed 07/10/07 1:07-cv-02409 Card Activation Technologies, Inc. v. [read post]
5 Apr 2023, 5:18 am
Birrs LJ also ventured further than this and asserted that the court can determine the validity of a foreign patent if it is relevant to the enforcement of the contract in Otsuka Pharmaceutical Co Ltd v GW Pharma Ltd [2022] EWCA Civ 1462. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
1 Dec 2007, 9:00 am
: (Trademark Blog), Short paper on domain name monetization: (Trademark Blog),Comcast puts non-lawyer in charge of IP Strategy: (IAM),Are green technology IP rights owners about to become the new big pharma? [read post]
26 Apr 2021, 3:32 am
Gilead Sciences, Inc. v. [read post]
12 Dec 2014, 3:11 am
., Inc. v. [read post]
28 Apr 2008, 11:00 am
: Art, access and the public domain after Bridgeman v Corel’ – 29 April, New York City: (creativecommons.org), (Public Knowledge) US: ACI ‘Paragraph IV disputes’ conference – 30 April – 1 May, New York City: (Orange Book Blog) Pharma & Biotech Pharma & Biotech - General Canada: Patented Medicine Prices Review Board (PMPRB) departs from its guidelines in determining price in recent decision:… [read post]
7 Oct 2010, 11:02 am
ICG America, Inc., 2010 WL 3522982 (D. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
25 Jan 2008, 1:00 am
: (IP ThinkTank),IBM patents and defensive publishing: (Securing Innovation),Stockholm Network paper on developing nations and pharmaceutical patents: (IPcentral Weblog),Good and bad news for the IP industry if recession does bite: (IAM),Business Software Alliance: Piracy economic impact is tens of billions of dollars: (Ars Technica),IP portfolio costs - when less is more: (IP ThinkTank),IP protection: Competitive market default: (The Fire… [read post]
